Leukemia Research
Volume 28, Issue 10 , Pages 1057-1067 , October 2004

Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: A randomised phase II trial from HOVON, the Dutch–Belgian Haemato-Oncology Working Group for adults

  • Simon Daenen

      Affiliations

    • Department of Haematology, University Hospital, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31-50-3616161; fax: +31-50-3614862.
  • ,
  • Bronno van der Holt

      Affiliations

    • HOVON Data Center, Erasmus Medical Center, Rotterdam, The Netherlands
  • ,
  • Gregor E.G Verhoef

      Affiliations

    • Academic Hospital Gasthuisberg, Leuven, Belgium
  • ,
  • Bob Löwenberg

      Affiliations

    • Erasmus Medical Center, Rotterdam, The Netherlands
  • ,
  • Pierre W Wijermans

      Affiliations

    • Leyenburg Hospital, The Hague, The Netherlands
  • ,
  • Peter C Huijgens

      Affiliations

    • VU University Medical Center, Amsterdam, The Netherlands
  • ,
  • Rien van Marwijk Kooy

      Affiliations

    • Isala Clinics, Zwolle, The Netherlands
  • ,
  • Harry C Schouten

      Affiliations

    • University Hospital, Maastricht, The Netherlands
  • ,
  • Mark H.H Kramer

      Affiliations

    • Eemland Hospital, Amersfoort, The Netherlands
  • ,
  • Augustin Ferrant

      Affiliations

    • Free University Hospital, Brussels, Belgium
  • ,
  • Eva van den Berg

      Affiliations

    • Department of Medical Genetics, Groningen, The Netherlands
  • ,
  • Monique M.C Steijaert

      Affiliations

    • HOVON Data Center, Erasmus Medical Center, Rotterdam, The Netherlands
  • ,
  • Leo F Verdonck

      Affiliations

    • University Hospital, Utrecht, The Netherlands
  • ,
  • Pieter Sonneveld

      Affiliations

    • Erasmus Medical Center, Rotterdam, The Netherlands

Received 27 November 2003 ,Accepted 2 March 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(04)00063-3

doi: 10.1016/j.leukres.2004.03.001

Leukemia Research
Volume 28, Issue 10 , Pages 1057-1067 , October 2004